Renal Cell Cancer Update

For this special edition of Oncology Today, I met with Dr Pasi Jänne from the Dana-Farber Cancer Institute in Boston, Massachusetts to discuss recently published and emerging research in the management of EGFR mutation-positive non-small cell lung cancer. CME information and select publications here (https://www.researchtopractice.com/OncologyTodayEGFRNSCLC20).